公司资料
COMPASS Pathways Plc 股价、新闻与催化剂
- 股票代码:
- CMPS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom
股票表现
14.20 USD (+6.53%)
收盘价
最后更新: 2026年8月24日
1.8B USD
市值
股价为何变动
As of Aug 24, 2026, CMPS closed up 6.53% at $14.20. No new same-company headline was identified in the current news window.
公司概览
业务概览
COMPASS Pathways is a neuroscience company focused on psychedelic-assisted therapy and depression. Its story is centered on whether a novel mental-health paradigm can be translated into regulated medicine.
所在地与行业分类
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, COMPASS sits in specialty neuroscience biotechnology.
商业模式特征
The company depends on clinical data, regulatory progress, and the commercial viability of a new treatment model for depression.
生物医药行业定位
COMPASS is a high-catalyst CNS name whose value is heavily tied to clinical and regulatory outcomes.
未来催化剂
- Compass Pathways’s key catalyst is COMP360 in treatment-resistant depression, with the next clinical and regulatory steps doing most of the work. The market will react quickly if the psilocybin story keeps building toward a viable commercial path.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。